** Shares of life insurer Globe Life GL.N down 1.2% at $138.98 premarket
** Evercore ISI downgrades stock to "in-line" from "outperform", maintains PT at $155
** With favorable outcomes on the resolution of regulatory risk, improved future free cash flow from its planned use of Bermuda based captive reinsurance, we think there is solid visibility, but not really a great case for further re-rating, brokerage says
** On the fundamentals, if the lower end consumer softens, this could turn sales and revenue headwind for GL for life insurance, it adds
** Evercore ISI says there is still some turmoil in the health markets more broadly – this could mean more volatility in these results in 2026 and 2027
** Nine of 11 brokerages rate stock "buy" or higher, 2 "hold"; median PT is $168.5 — data compiled by LSEG
** GL stock rose 25% in 2025
(Reporting by Koyena Das in Bengaluru)
((koyena.das@thomsonreuters.com))
Comments